Company Profile
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc.
At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Key Executives
Chief Executive Officer | |
Chief Financial Officer | |
Chief Investor Relations Officer | |
Director of Sustainable Development | |
Chief Human Resources Officer |
Key Figures
Millenium | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Net sales | 1,148,210 | 1,361,138 | 1,237,654 | 881,305 | 706,319 |
Income from ordinary activities | 1,148,210 | 1,361,138 | 1,237,654 | 881,305 | 706,319 |
Operating income | 216,261 | 351,260 | 419,499 | 324,226 | 217,861 |
Cost of financial indebtedness net | 28,291 | 34,072 | 22,506 | 1,375 | 1,279 |
Equity-accounted companies contribution to income | |||||
Net profit from discontinued activities | |||||
Net income | 158,508 | 240,110 | 310,732 | 248,296 | 175,735 |
Net income (Group share) | 159,849 | 240,907 | 310,968 | 247,871 | 175,735 |
Fiscal year end | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
Account Standards | IFRS | IFRS | IFRS | IFRS | IFRS |
Shareholder information
Chen Menachem Even | |
Carlo Rosa | |
Finde SS | |
Free float | |
T. Rowe Price Associates, Inc. |
Address
DiaSorin S.p.A.
Via Crescentino snc
IT-13040 Saluggia
Italy
Phone number: +39 (0)161 487 1
https://diasoringroup.com/
Contact
Please contact MyQuestion.Italy@euronext.com for Company Profile support.